The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Brainstorm Cell Therapeutics, Inc.’s current trading price is -93.83% away from its 52-week high, while its distance from the 52-week low is 59.25%. The stock’s price range for this period has been between $0.13 and $3.46 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 4.74 million for the day, a number notably higher than the average daily volume of 1.99 million over the last three months.
At present, Brainstorm Cell Therapeutics, Inc. (BCLI) has a stock price of $0.21. In the previous session, the stock saw a rise, peaking at $0.196 after an opening price of $0.19. The day’s lowest price was $0.174, and it closed at $0.18.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
Brainstorm Cell Therapeutics, Inc. ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $3.46 on 03/31/23, while the lowest value for the same period was recorded at $0.13 on 10/31/23.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Brainstorm Cell Therapeutics, Inc. (BCLI) has experienced a quarterly decline of -86.05% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 10.45M and boasts a workforce of 43 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.0239, with a change in price of -1.8040. Similarly, Brainstorm Cell Therapeutics, Inc. recorded 1,384,758 in trading volume during the last 100 days, posting a change of -90.20%.
BCLI Stock Stochastic Average
Brainstorm Cell Therapeutics, Inc.’s raw stochastic average for the past 50 days is presently 4.86%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 81.58%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 67.63% and 62.12%, respectively.
BCLI Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. Year to date metric has recorded a loss of -86.99%.However, over the last six months, we can see a stronger performance of -93.00%. Over the last 30 days, the price of BCLI has fallen by 27.10%. And in the last five days, it has surged by 15.10%.
